A critical breakthrough in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in several kinds of cancer, causing https://mediajx.com/story298887/mini-antibodies-revive-the-p53-protein-new-new-approach-for-tumor-therapy